SPC331
Avapritinib eða lyfjafræðilega viðunandi sölt þar af
Status:
VeittApplication date:
24.3.2021Application published:
15.4.2021Grant published:
15.10.2023
Max expiry date:
24.9.2035Medicine name:
AYVAKYTMedicine for children:
No
Timeline
Today
24.3.2021Application
15.4.2021Publication
15.10.2023Registration
24.9.2035Expires
Marketing license
IS authorization number:
EU1/20/1473/001; EU1/20/1473/002; EU1/20/1473/003Date:
24.9.2020
Foreign authorization number:
EU1/20/1473Date:
24.9.2020
Owner
Name:
Blueprint Medicines CorporationAddress:
45 Sidney Street, Cambridge, MA US
Agent
Name:
Budde Schou A/SAddress:
Dronningens Tværgade 30, 1302 Copenhagen K
Patent
Number:
EP3057969